Health Care & Life Sciences » Pharmaceuticals | Heron Therapeutics Inc.

Heron Therapeutics Inc. | Mutual Funds

Mutual Funds that own Heron Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Growth Company Fund
2,707,492
3.48%
-40,731
0.22%
07/31/2018
SPDR S&P Biotech ETF
2,405,984
3.1%
6,189
1.58%
09/06/2018
Janus Triton Fund
2,347,401
3.02%
0
0.77%
06/30/2018
Vanguard Total Stock Market Index Fund
1,734,064
2.23%
1,610
0.01%
07/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,712,420
2.2%
-639,500
2.84%
06/30/2018
Franklin Biotechnology Discovery Fund
1,511,677
1.95%
-269,346
4%
03/31/2018
Fidelity Select Biotechnology Portfolio
1,411,479
1.82%
291,400
0.59%
07/31/2018
iShares Russell 2000 ETF
1,340,726
1.73%
-717
0.11%
09/06/2018
Eagle Small Cap Growth Fund
1,274,695
1.64%
1,274,695
0.85%
06/29/2018
Fidelity OTC Portfolio
1,252,815
1.61%
0
0.22%
07/31/2018

About Heron Therapeutics

View Profile
Address
4242 Campus Point Court
San Diego California 92121
United States
Employees -
Website http://www.herontx.com
Updated 07/08/2019
Heron Therapeutics, Inc. is a biotechnology company, which develops pharmaceutical products for patients suffering from cancer. The company develops products by using its proprietary Biochronomer polymer based drug delivery technology. Its products include SUSTOL, Pipeline, Cinvanti and HTX-011.